{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:28Z","timestamp":1790187088848,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2018.00362","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T09:33:07Z","timestamp":1543311187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome"],"prefix":"10.3389","volume":"6","author":[{"given":"Chris","family":"Wincup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiannis","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-4939-0326-9_17","article-title":"Laboratory tests for the antiphospholipid syndrome","volume":"1134","author":"Pericleous","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-62703-339-8_7","article-title":"Lupus anticoagulant testing","volume":"992","author":"Moffat","year":"2013","journal-title":"Methods Mol Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1182\/blood-2007-12-129627","article-title":"How we diagnose the antiphospholipid syndrome","volume":"113","author":"Giannakopoulos","year":"2009","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000461988","article-title":"Positive direct antiglobulin test due to antiphospholipid antibodies in normal healthy blood donors","volume":"72","author":"Win","year":"1997","journal-title":"Vox Sang"},{"key":"B6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/bjh.13030","article-title":"Lupus anticoagulant testing and anticoagulation do not mix: quantitation of discrepant results and potential approaches to reduce false positives","volume":"167","author":"Chandler","year":"2014","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/1744666X.2014.968129","article-title":"Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome","volume":"10","author":"Chighizola","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1160\/TH14-03-0191","article-title":"Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity","volume":"112","author":"Ruffatti","year":"2014","journal-title":"Thromb Haemost"},{"key":"B9","first-page":"531","article-title":"Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome","volume":"33","author":"Stojanovich","year":"2015","journal-title":"Clin Exp Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"951424","DOI":"10.1155\/2015\/951424","article-title":"Treatment of thrombotic antiphospholipid syndrome: the rationale of current management-an insight into future approaches","volume":"2015","author":"Chighizola","year":"2015","journal-title":"J Immunol Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"341342","DOI":"10.1155\/2014\/341342","article-title":"An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions","volume":"2014","author":"Emmi","year":"2014","journal-title":"Sci World J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17474086.2016.1235969","article-title":"What is known about pediatric antiphospholipid syndrome?","volume":"9","author":"Meroni","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0889-857X(05)70351-3","article-title":"Antiphospholipid antibody syndrome in pediatric patients","volume":"23","author":"Ravelli","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11926-009-0072-7","article-title":"Antibodies to serine proteases in the antiphospholipid syndrome","volume":"12","author":"Chen","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome","volume":"15","author":"Meroni","year":"2000","journal-title":"J Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome","volume":"12","author":"Krone","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-0037-1614491","article-title":"Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus\u2013possible association with thrombotic and thrombocytopenic complications","volume":"81","author":"Nojima","year":"1999","journal-title":"Thromb Haemost"},{"key":"B19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.thromres.2004.06.045","article-title":"Inflammatory response and the endothelium","volume":"114","author":"Meroni","year":"2004","journal-title":"Thromb Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1719720","DOI":"10.1155\/2016\/1719720","article-title":"The role of TLR4 on B cell activation and Anti-beta2GPI antibody production in the antiphospholipid syndrome","volume":"2016","author":"Cheng","year":"2016","journal-title":"J Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/0961203315603146","article-title":"Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4","volume":"25","author":"Laplante","year":"2016","journal-title":"Lupus"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry","volume":"122","author":"Avcin","year":"2008","journal-title":"Pediatrics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1055\/s-0028-1082272","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment","volume":"34","author":"Miesbach","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"B24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0002-9378(16)32527-3","article-title":"Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant","volume":"142","author":"De Wolf","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/art.1780310307","article-title":"Lupus pregnancy","volume":"31","author":"Hanly","year":"1988","journal-title":"Arthritis Rheum"},{"key":"B26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0046-8177(96)90377-9","article-title":"Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature","volume":"27","author":"Nayar","year":"1996","journal-title":"Hum Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/s-0032-1311827","article-title":"Pathogenesis of the antiphospholipid syndrome","volume":"38","author":"Willis","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"B28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1055\/s-0035-1556725","article-title":"Antiphospholipid syndrome - not a noninflammatory disease","volume":"41","author":"de Groot","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"B29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.10130","article-title":"Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo","volume":"46","author":"Gharavi","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B30","first-page":"1393","article-title":"A family study of the antiphospholipid syndrome associated with other autoimmune diseases","volume":"19","author":"Dagenais","year":"1992","journal-title":"J Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/art.1780350119","article-title":"Major histocompatibility complex associations with primary antiphospholipid syndrome","volume":"35","author":"Asherson","year":"1992","journal-title":"Arthritis Rheum"},{"key":"B32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.autrev.2016.01.005","article-title":"Genetic aspects of the antiphospholipid syndrome: An update","volume":"15","author":"Sebastiani","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.40195","article-title":"Major histocompatibility complex class II alleles influence induction of pathogenic antiphospholipid antibodies in a mouse model of thrombosis","volume":"69","author":"Papalardo","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/art.27345","article-title":"IRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factor","volume":"62","author":"Fredi","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1002\/art.24701","article-title":"Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome","volume":"60","author":"Yin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/art.22360","article-title":"Antiphospholipid syndrome and recurrent thrombosis in children","volume":"55","author":"Berkun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","article-title":"Differences in disease phenotype and severity in SLE across age groups","volume":"25","author":"Ambrose","year":"2016","journal-title":"Lupus"},{"key":"B39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-015-0504-5","article-title":"Pediatric Antiphospholipid Syndrome","volume":"17","author":"Aguiar","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/096120339700600616","article-title":"Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis","volume":"6","author":"Andrews","year":"1997","journal-title":"Lupus"},{"key":"B41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/adc.86.2.132","article-title":"Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura","volume":"86","author":"Monastiri","year":"2002","journal-title":"Arch Dis Child"},{"key":"B42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0961203308091634","article-title":"Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome","volume":"17","author":"Megli\u010d","year":"2008","journal-title":"Lupus"},{"key":"B43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/096120330000900108","article-title":"Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome","volume":"9","author":"Sherer","year":"2000","journal-title":"Lupus"},{"key":"B44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-2007-973468","article-title":"Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood","volume":"30","author":"Kiechl-Kohlendorfer","year":"1999","journal-title":"Neuropediatrics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1191\/0961203303lu411oa","article-title":"Outcome of primary antiphospholipid syndrome in childhood","volume":"12","author":"Gattorno","year":"2003","journal-title":"Lupus"},{"key":"B47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/01.md.0000172074.53583.ea","article-title":"Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?","volume":"84","author":"Gomez-Puerta","year":"2005","journal-title":"Medicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"Evidence based recommendations for diagnosis and treatment of the antiphospholipid syndrome in children - results of the share initiative","volume":"25","author":"Avcin","year":"2016","journal-title":"Lupus"},{"key":"B49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0022-3476(96)70064-1","article-title":"Clinical characteristics of antiphospholipid antibody syndrome in children","volume":"129","author":"von Scheven","year":"1996","journal-title":"J Pediatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF01957376","article-title":"Antiphospholipid syndrome in young patients","volume":"154","author":"Di Nucci","year":"1995","journal-title":"Two cases of cerebral ischaemic accidents Eur J Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1177\/0961203314531842","article-title":"Antiphospholipid antibodies in neonates with stroke\u2013a unique entity or variant of antiphospholipid syndrome?","volume":"23","author":"Berkun","year":"2014","journal-title":"Lupus"},{"key":"B53","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.mehy.2011.02.030","article-title":"Pediatric cerebellar stroke associated with elevated titer of antibodies to beta2-glycoprotein","volume":"76","author":"Spalice","year":"2011","journal-title":"Med Hypotheses"},{"key":"B54","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1468-2982.2004.00752.x","article-title":"Estimation of antiphospholipid antibodies in a prospective longitudinal study of children with migraine","volume":"24","author":"Avcin","year":"2004","journal-title":"Cephalalgia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/BF02724305","article-title":"Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome","volume":"71","author":"Shaharao","year":"2004","journal-title":"Indian J Pediatr"},{"key":"B56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0887-8994(00)00152-1","article-title":"Antiphospholipid- associated recurrent chorea and ballism in a child with cerebral palsy","volume":"23","author":"Okun","year":"2000","journal-title":"Pediatr Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1191\/0961203303lu471oa","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus","volume":"12","author":"Campos","year":"2003","journal-title":"Lupus"},{"key":"B58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.autrev.2006.11.005","article-title":"Ocular manifestations in antiphospholipid syndrome","volume":"6","author":"Suvajac","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B59","first-page":"373","article-title":"Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies","volume":"11","author":"Golstein","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"B60","first-page":"768","article-title":"Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome","volume":"22","author":"Miller","year":"1995","journal-title":"J Rheumatol"},{"key":"B61","first-page":"435","article-title":"Non-ST-elevation acute myocardial infarction secondary to antiphospholipid antibody syndrome in an adolescent female","volume":"78","author":"Moreno-Ruiz","year":"2010","journal-title":"Cir Cir"},{"key":"B62","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00246-002-0273-6","article-title":"Primary antiphospholipid antibody syndrome and cardiac involvement in a child","volume":"24","author":"Clauss","year":"2003","journal-title":"Pediatr Cardiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/PEC.0b013e31820d8dd4","article-title":"Pulmonary thromboembolism as the initial manifestation in a child with antiphospholipid syndrome in the emergency department","volume":"27","author":"Bhat","year":"2011","journal-title":"Pediatr Emerg Care"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s10067-017-3776-5","article-title":"Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients","volume":"37","author":"Ma","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00467-011-2085-5","article-title":"Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome","volume":"27","author":"Noda","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00467-004-1491-3","article-title":"End-stage renal disease from glomerulonephritis associated with anti-phospholipid syndrome","volume":"19","author":"Butani","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B67","first-page":"102","article-title":"Atypical renal onset and involvement in primary antiphospholipid syndrome in a child","volume":"16","author":"Minisola","year":"1998","journal-title":"Clin Exp Rheumatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/jc.2012-4300","article-title":"Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients","volume":"98","author":"Ramon","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MBC.0b013e32809cc95a","article-title":"Antiphospholipid antibodies in Turkish children with thrombosis","volume":"18","author":"Tavil","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/17402520600877778","article-title":"Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome","volume":"13","author":"Chang","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1055\/s-0028-1082271","article-title":"Pediatric antiphospholipid antibodies and antiphospholipid syndrome","volume":"34","author":"Hunt","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"B72","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/rheumatology\/40.5.565","article-title":"Anticardiolipin and anti-\u03b22 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits","volume":"40","author":"Av\u010din","year":"2001","journal-title":"Rheumatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e0156407","DOI":"10.1371\/journal.pone.0156407","article-title":"Measuring IgA Anti-beta2-Glycoprotein I, and IgG\/IgA Anti-Domain I antibodies adds value to current serological assays for the antiphospholipid syndrome","volume":"11","author":"Pericleous","year":"2016","journal-title":"PLoS ONE"},{"key":"B74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/annrheumdis-2014-206483","volume":"74","author":"Cousins","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0961203307079036","article-title":"Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome","volume":"16","author":"Avcin","year":"2007","journal-title":"Lupus"},{"key":"B76","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/adc.66.6.713","article-title":"Thrombosis in systemic lupus erythematosus: a French collaborative study","volume":"66","author":"Montes","year":"1991","journal-title":"Arch Dis Child."},{"key":"B77","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1542\/peds.92.6.849","article-title":"Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives","volume":"92","author":"Molta","year":"1993","journal-title":"Pediatrics"},{"key":"B78","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0272-6386(97)90195-5","article-title":"Antiphospholipid antibodies in pediatric lupus nephritis","volume":"29","author":"Massengill","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"B79","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1542\/peds.96.6.1040","article-title":"Antiphospholipid antibodies in pediatric systemic lupus erythematosus","volume":"96","author":"Seaman","year":"1995","journal-title":"Pediatrics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B83","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","article-title":"Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome","volume":"14","author":"Belizna","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B84","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/ard.2007.078402","article-title":"B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres","volume":"67","author":"Ioannou","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial","volume":"3","author":"Cohen","year":"2016","journal-title":"Lancet Haematol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2058738418778121","DOI":"10.1177\/2058738418778121","article-title":"Thrombotic storm in a 4-year-old boy with a thrombus in the right atrium","volume":"32","author":"Ma","year":"2018","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2223\/JPED.2227","article-title":"Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases","volume":"88","author":"Bugni","year":"2012","journal-title":"J Pediatr"},{"key":"B88","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.autrev.2013.10.004","article-title":"Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the \u201dCAPS Registry\u201c","volume":"13","author":"Berman","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e1523","DOI":"10.1542\/peds.2009-2939","article-title":"Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab","volume":"125","author":"Iglesias-Jim\u00e9nez","year":"2010","journal-title":"Pediatrics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B93","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.siny.2006.01.005","article-title":"Neonatal thromboembolic emergencies","volume":"11","author":"Thornburg","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.siny.2011.07.005","article-title":"Thrombophilia testing in neonates and infants with thrombosis","volume":"16","author":"Nowak-G\u00f6ttl","year":"2011","journal-title":"Semin Fetal Neonatal Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0961203307079039","article-title":"Infant perinatal thrombosis and antiphospholipid antibodies: a review","volume":"16","author":"Boffa","year":"2007","journal-title":"Lupus"},{"key":"B96","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","article-title":"European registry of babies born to mothers with antiphospholipid syndrome","volume":"72","author":"Mekinian","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T23:12:49Z","timestamp":1662505969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2018.00362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":97,"alternative-id":["10.3389\/fped.2018.00362"],"URL":"https:\/\/doi.org\/10.3389\/fped.2018.00362","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"362"}}